Estimating GFR

This episode examines the evolving landscape of kidney function assessment in endocrine care, focusing on the limitations of traditional creatinine and the clinical utility of cystatin C. We explore how modern estimating equations have eliminated race to improve diagnostic equity, and analyze how common therapies like SGLT2 inhibitors impact renal metrics without causing true injury. Listeners will learn why combining multiple biomarkers provides the most reliable strategy for monitoring renal health and predicting long term patient outcomes.